Voltaren Xr

Voltaren Xr

Voltaren Xr Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.


Carefully consider the potential benefits and risks of Voltaren®-XR (diclofenac sodium extended-release) tablets, USP and other treatment options before deciding to use Voltaren-XR. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS).

      Voltaren-XR is indicated:

  • For relief of the signs and symptoms of osteoarthritis
  • For relief of the signs and symptoms of rheumatoid arthritis


There is currently no drug history available for this drug.

Other Information

Voltaren®-XR (diclofenac sodium extended-release) tablets, USP is a benzeneacetic acid derivative. Voltaren-XR is available as extended-release tablets of 100 mg (light pink) for oral administration. The chemical name is 2-[(2,6-dichlorophenyl)amino] benzeneacetic acid, monosodium salt. The molecular weight is 318.14. Its molecular formula is C14H10Cl2NNaO2, and it has the following structural formula

      Voltaren XR (diclofenac sodium extended release) structural formula

The inactive ingredients in Voltaren-XR include: cetyl alcohol, hydroxypropyl methylcellulose, iron oxide, magnesium stearate, polyethylene glycol, polysorbate, povidone, silicon dioxide, sucrose, talc, titanium dioxide.

Voltaren Xr Manufacturers

  • Novartis Pharmaceuticals Corporation
    Voltaren Xr (Diclofenac Sodium Extended Release Tablets) Tablet, Film Coated, Extended Release [Novartis Pharmaceuticals Corporation]

Login To Your Free Account